Imre Bard
London School of Economics and Political Science
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Imre Bard.
PLOS ONE | 2014
Ilina Singh; Imre Bard; Jonathan Jackson
Use of ‘smart drugs’ among UK students is described in frequent media reports as a rapidly increasing phenomenon. This article reports findings from the first large-scale survey of pharmacological cognitive enhancement (PCE) among students in the UK and Ireland. Conducted from February to September 2012, a survey of a convenience sample of 877 students measured PCE prevalence, attitudes, sources, purposes and ethics. Descriptive and logistic regression statistical methods were used to analyse the data. Lifetime prevalence of PCE using modafinil, methylphenidate or Adderall was under 10%, while past regular and current PCE users of these substances made up between 0.3%–4% of the survey population. A substantial majority of students was unaware of and/or uninterested in PCE; however about one third of students were interested in PCE. PCE users were more likely to be male, British and older students; predictors of PCE use included awareness of other students using PCEs, ADHD symptomatology, ethical concerns, and alcohol and cannabis use. The survey addresses the need for better evidence about PCE prevalence and practices among university students in the UK. We recommend PCE-related strategies for universities based on the survey findings.
Current Psychiatry Reports | 2013
Ilina Singh; Angela M. Filipe; Imre Bard; Meredith Bergey; Lauren Baker
Globalization of ADHD and the rise of cognitive enhancement have raised fresh concerns about the validity of ADHD diagnosis and the ethics of stimulant drug treatment. We review the literature on these two emerging phenomena, with a focus on the corresponding social, scientific and ethical debates over the universality of ADHD and the use of stimulant drug treatments in a global population of children and adolescents. Drawing on this literature, we reflect on the importance of ethically informed, ecologically sensitive clinical practices in relation to ADHD diagnosis and treatment.
Journal of Psychoactive Drugs | 2011
Levente Móró; Katalin Simon; Imre Bard; József Rácz
Abstract Psychoactive drug use shows great diversity, but due to a disproportionate focus on problematic drug use, predominant nonproblematic drug use remains an understudied phenomenon. Historic and anecdotal evidence shows that natural sources of “psychedelic” drugs (e.g., mescaline and psilocybin) have been used in religious and spiritual settings for centuries, as well as for psychological self-enhancement purposes. Our study assessed a total of 667 psychedelic drug users, other drug users, and drug nonusers by online questionnaires. Coping, life purpose, and spirituality were measured with the Psychological Immune Competence Inventory, the Purpose in Life test, and the Intrinsic Spirituality Scale, respectively. Results indicate that the use of psychedelic drugs with a purpose to enhance self-knowledge is less associated with problems, and correlates positively with coping and spirituality. Albeit the meaning of “spirituality” may be ambiguous, it seems that a spiritually-inclined attitude in drug use may act as a protective factor against drug-related problems. The autognostic use of psychedelic drugs may be thus hypothesized as a “training situation” that promotes self-enhancement by rehearsing personal coping strategies and by gaining self-knowledge. However, to assess the actual efficiency and the speculated long-term benefits of these deliberately provoked exceptional experiences, further qualitative investigations are needed.
Nature Biotechnology | 2017
George Gaskell; Imre Bard; Agnes Allansdottir; R V da Cunha; Peter Eduard; Juergen Hampel; Elisabeth Hildt; C Hofmaier; Nicole Kronberger; Sheena Laursen; Anna Meijknecht; Salvör Nordal; Alexandre Quintanilha; Gemma Revuelta; Núria Saladié; Judit Sándor; J B Santos; S Seyringer; Ilina Singh; Han Somsen; Winnie Toonders; Helge Torgersen; Vincent Torre; M Varju; H.A.E. Zwart
This paper reports on an online contrastive vignette study investigating the publics views of gene editing for therapy and enhancement in adult and prenatal contexts. The study, comprising quota samples of 1000 respondents per country, involved 10 European countries and the United States. Vignettes featuring gene editing for therapy compared to enhancement are seen as more morally acceptable and gain more support. Adult therapy attracts majority support, while prenatal enhancement elicits almost complete rejection. The assessment of adult enhancement and prenatal therapy are more ambivalent. These results and the respondents’ accounts of the reasons behind the decision point to a focus on the uses of gene editing, rather than the technology itself. The study is a contribution to understanding the practical dimensions of the ethical question: how can gene editing contribute to human flourishing?
Neuroethics | 2018
Imre Bard; George Gaskell; Agnes Allansdottir; Rui Vieira da Cunha; Peter Eduard; Juergen Hampel; Elisabeth Hildt; Christian Hofmaier; Nicole Kronberger; Sheena Laursen; Anna Meijknecht; Salvör Nordal; Alexandre Quintanilha; Gema Revuelta; Núria Saladié; Judit Sándor; Júlio Borlido Santos; Simone Seyringer; Ilina Singh; Han Somsen; Winnie Toonders; Helge Torgersen; Vincent Torre; Márton Varju; H.A.E. Zwart
Neuroenhancement involves the use of neurotechnologies to improve cognitive, affective or behavioural functioning, where these are not judged to be clinically impaired. Questions about enhancement have become one of the key topics of neuroethics over the past decade. The current study draws on in-depth public engagement activities in ten European countries giving a bottom-up perspective on the ethics and desirability of enhancement. This informed the design of an online contrastive vignette experiment that was administered to representative samples of 1000 respondents in the ten countries and the United States. The experiment investigated how the gender of the protagonist, his or her level of performance, the efficacy of the enhancer and the mode of enhancement affected support for neuroenhancement in both educational and employment contexts. Of these, higher efficacy and lower performance were found to increase willingness to support enhancement. A series of commonly articulated claims about the individual and societal dimensions of neuroenhancement were derived from the public engagement activities. Underlying these claims, multivariate analysis identified two social values. The Societal/Protective highlights counter normative consequences and opposes the use enhancers. The Individual/Proactionary highlights opportunities and supports use. For most respondents these values are not mutually exclusive. This suggests that for many neuroenhancement is viewed simultaneously as a source of both promise and concern.
Neuropharmacology | 2013
C. Ian Ragan; Imre Bard; Ilina Singh
Neuropharmacology | 2013
C. Ian Ragan; Imre Bard; Ilina Singh
Archive | 2017
Imre Bard; Ilina Singh; Peter Eduard
Archive | 2014
Imre Bard; Ilina Singh
LSE Research Online Documents on Economics | 2014
Ilina Singh; Imre Bard; Jonathan Jackson